Hudson Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Hudson Capital Management's AMGN Position: Q3 2021 in Review
Hudson Capital Management sold out of Amgen (AMGN) in Q3 2021, closing a stake of 8,741 shares — an estimated $2.13M sold.
Hudson Capital Management first reported a position in AMGN in Q4 2017 and held it in 15 quarters. The position peaked at $2.4M in Q4 2019. 2,131 funds tracked by Wall St. Rank hold AMGN as of Q3 2021.
- Hudson Capital Management reported no remaining Amgen position as of Q3 2021 after selling out during the quarter.
- Hudson Capital Management sold 8,741 Amgen shares in Q3 2021, an estimated $2.13M.
- Hudson Capital Management first reported a position in Amgen in Q4 2017 and held it in 15 quarters.
- Hudson Capital Management's Amgen position peaked at $2.4M in Q4 2019.
- 2,131 funds tracked by Wall St. Rank held Amgen as of Q3 2021.
Based on Hudson Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.